Cutis laxa, autosomal recessive, type 2bQ82.8

Authors:Prof. Dr. med. Peter Altmeyer, Prof. Dr. med. Martina Bacharach-Buhles

All authors of this article

Last updated on: 22.09.2022

Dieser Artikel auf Deutsch

Synonym(s)

ARCL2B; Autosomal recessive cutis laxa, type 2B; Cutis laxa, autosomal recessive, type 2B; Cutis laxa with progeroid characteristics; de-Barsy Syndrome B; OMIM: 612940; Progeroid Cutis laxa; PYCR-1-related progeroid syndromes

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

DefinitionThis section has been translated automatically.

Cutis laxa is the name given to a heterogeneous group of hereditary diseases characterized by a pendulous, inelastic (in contrast to Marfan's syndrome and Ehlers-Danlos syndrome) skin. These cutaneous and systemic features are almost always due to loss, fragmentation or severe disorganisation of the dermal elastic fibres. The hereditary forms of cutis laxa are caused by mutations in genes which are functionally involved in the build-up or breakdown of elastic fibres. In principle, autosomal dominant forms can be distinguished from autosomal recessive forms, independent of the gene system. If the clinical phenomenon "cutis laxa" or better "cutis-laxa-like skin changes" is considered from a differential diagnostic point of view, further hereditary as well as acquired clinical pictures have to be considered.

EtiopathogenesisThis section has been translated automatically.

Present is a mutation at the PYCR1 gene (pyrroline-5-carboxylate reductase 1 - gene location 17q25.3), a protein-coding gene encoding an enzyme of the same name localized in the mitochodria that catalyzes the NAD (P) H-dependent conversion of pyrroline-5-carboxylate to proline. This enzyme may also play a physiological role in the generation of NADP (+) in some cell types. The protein forms a homopolymer and localizes to the mitochondrion. Alternative splicing results in multiple transcript variants.

Clinical featuresThis section has been translated automatically.

The clinical spectrum of autosomal recessive cutis laxa is very heterogeneous with respect to organ involvement and severity. Autosomal recessive cutis laxa, type 2B is characterized by clinical prognathism, elongated face, osteopenia, and cutis laxa on the back of the hand and foot. Pulmonary emphysema, common in other cutis laxa variants, is absent. Patients with PYCR1 mutations are usually severely mentally disabled (Yildirim Y et al. 2010).

Note(s)This section has been translated automatically.

There is a large phenotypic correspondence with Geroderma osteodysplasticum, which is based on an autosomal recessive mutation in the GORAB gene.

LiteratureThis section has been translated automatically.

  1. Adams E et al (1960) Hydroxyproline metabolism. III. enzymatic synthesis of hydroxyproline from delta1-pyrroline-3-hydroxy-5-carboxylates J Biol Chem 235: 3499-3503.
  2. Meister A et al (1057) Enzymatic synthesis of L-pipecolic acid and L-proline. J Biol Chem 229: 789-800.
  3. Scherrer DZ et al (2013) Mutations in PYCR1 genes in three families with autosomal recessive cutis laxa, type 2 Eur J Med Genet 56:336-339.
  4. Yildirim Y et al (2010) The phenotype caused by PYCR1 mutations corresponds to geroderma osteodysplasticum rather than autosomal recessive cutis laxa type 2 at J Med Genet A 155A:134-140. https://www.ncbi.nlm.nih.gov/pubmed/21204221

Authors

Last updated on: 22.09.2022